wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34051972-1A34E911-9AF1-4A97-AAA2-4B077B0D5F80
Q34051972-1A34E911-9AF1-4A97-AAA2-4B077B0D5F80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34051972-1A34E911-9AF1-4A97-AAA2-4B077B0D5F80
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer
P2860
Q34051972-1A34E911-9AF1-4A97-AAA2-4B077B0D5F80
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34051972-1A34E911-9AF1-4A97-AAA2-4B077B0D5F80
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
78c4d40777d28c3565ffe63123275470815ddbba
P2860
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.